Jester J Gregory

Chief Financial Officer at CytRx Oncology Corp · on record since Oct 23, 2006
Chief Financial Officer at HUMANIGEN, INC · on record since Mar 13, 2018

Insider trading activity of Jester J Gregory

Transactions on record: 11; since Jul 12, 2007

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Jan 28, 2019

Figures computed from official regulatory filings — .

Companies where Jester J Gregory has traded

HUMANIGEN, INC4 tx · Jan 28, 2019
CytRx Oncology Corp7 tx · Sep 22, 2008

Track record of Jester J Gregory

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Jester J Gregory

Co-insiders of Jester J Gregory

5AM CO INVESTORS LLCHUMANIGEN, INC
5AM Partners LLCHUMANIGEN, INC
5AM VENTURES LLCHUMANIGEN, INC
Alloy Annex I, LLCHUMANIGEN, INC
Alloy Annex I, L.P.HUMANIGEN, INC
Alloy Corporate 2000, L.P.HUMANIGEN, INC
Alloy Investors 2000, L.P.HUMANIGEN, INC
Alloy Partners 2000, L.P.HUMANIGEN, INC
Alloy Ventures 2000, LLCHUMANIGEN, INC
Alloy Ventures 2000, L.P.HUMANIGEN, INC
Anthion Partners II LLCHUMANIGEN, INC
Azan AlainHUMANIGEN, INC
BAFFI ROBERTHUMANIGEN, INC
BARLIANT RONALDHUMANIGEN, INC
BAXTER INTERNATIONAL INCHUMANIGEN, INC
BIESTEK MAREKHUMANIGEN, INC
BLACK HORSE CAPITAL LPHUMANIGEN, INC
Black Horse Capital Management LLCHUMANIGEN, INC
Black Horse Capital Master Fund Ltd.HUMANIGEN, INC
Boehm Rainer J.HUMANIGEN, INC
Buxton CherylHUMANIGEN, INC
Chappell DaleHUMANIGEN, INC
CHASE ANTHONY RHUMANIGEN, INC
Cheval Holdings, Ltd.HUMANIGEN, INC
Cooper Jeffrey HHUMANIGEN, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
HUMANIGEN, INCListing unverified	Jan 28, 2019	AwardD (derivative)	86,111	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 13, 2018	AwardD (derivative)	1,073,815	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 13, 2018	AwardD (derivative)	284,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 7, 2018	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-37,500	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-37,500	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Feb 15, 2008	AwardD (derivative)	100,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Jul 12, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Jul 12, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
HUMANIGEN, INCListing unverified	Jan 28, 2019	AwardD (derivative)	86,111	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 13, 2018	AwardD (derivative)	1,073,815	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 13, 2018	AwardD (derivative)	284,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
HUMANIGEN, INCListing unverified	Mar 7, 2018	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-37,500	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Sep 22, 2008	OtherD (derivative)	-37,500	—	n/a (No price was disclosed in the filing)	SEC
CytRx Oncology CorpListing unverified	Feb 15, 2008	AwardD (derivative)	100,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Jul 12, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CytRx Oncology CorpListing unverified	Jul 12, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC